Anteris Technologies is known for its biomimetic transcatheter heart valve, the DurAVR THV System. The device is the first of its kind and has gained considerable attention as the TAVR market continues to grow.

“We're so focused on quickly taking care of the patient ... we may be forgetting about radiation safety,” one researcher explained. 

Abbott pointed to double-digit growth for its Navitor TAVR valve as well as big gains for the TriClip and MitraClip devices. The company also shared positive sales figures for its EP, heart failure and rhythm management portfolios. 

The Globe Pulsed Field System, which secured FDA approval in September 2025, features high-density mapping capabilities and a 122-electrode spherical array.

The diet, named after the traditional eating habits of Greece and Italy, is already known for its benefits to the general public. Its impact on heart patients, however, was less clear. 

Johnson & Johnson reported $24.6 billion in sales for the fourth quarter of 2025, up 9.1% from the previous year. On an earnings call with investors, the company's CEO sang the praises of the company's cardiovascular health division.

Mount Sinai Hospital in New York is now using AI-powered virtual agents to call some patients before cath lab procedures. The move was designed to help nurses focus more on patient care and reduce their risk of burnout.

Extravascular ICDs were developed to avoid complications such as vascular injuries, lead fractures and lead infections. Although rare, these issues can cause serious, life-threatening complications for patients.

Atherectomy is associated with rising healthcare costs, making it important to learn as much about the procedure's long-term value as possible. 

President Trump, 79, says he is still in excellent health. He also has no intention of cutting down on the high dose of aspirin he takes each day.

Nick West, MD, Shockwave Medical's chief medical officer, detailed how the company is continuing to push IVL technologies forward. "We are leading the space ... we have no intention of giving up that position," he said.

This is a Class I recall, which means the FDA believes these devices could cause a serious injury or death.

The cyberattack on Central Maine Healthcare happened in summer 2025, but the investigation was complicated by the hackers having access to systems for several months. A class action lawsuit is pending in state court. 

The American Academy of Pediatrics and co-plaintiffs are tightening the screws in their lawsuit against HHS Secretary Robert F. Kennedy Jr. and other healthcare leaders in the Trump administration.